Literature DB >> 33388780

Association Between Upper Respiratory Tract Viral Load, Comorbidities, Disease Severity, and Outcome of Patients With SARS-CoV-2 Infection.

Helena C Maltezou1, Vasilios Raftopoulos2, Rengina Vorou3, Kalliopi Papadima3, Kassiani Mellou3, Nikolaos Spanakis4, Athanasios Kossyvakis5, Georgia Gioula6, Maria Exindari6, Elisavet Froukala4, Beatriz Martinez-Gonzalez5, Georgios Panayiotakopoulos7, Anna Papa6, Andreas Mentis5, Athanasios Tsakris4.   

Abstract

BACKGROUND: There is limited information on the association between upper respiratory tract (URT) viral loads, host factors, and disease severity in SARS-CoV-2-infected patients.
METHODS: We studied 1122 patients (mean age, 46 years) diagnosed by polymerase chain reaction (PCR). URT viral load, measured by PCR cycle threshold, was categorized as high, moderate, or low.
RESULTS: There were 336 (29.9%) patients with comorbidities; 309 patients (27.5%) had high, 316 (28.2%) moderate, and 497 (44.3%) low viral load. In univariate analyses, compared to patients with moderate or low viral load, patients with high viral load were older, more often had comorbidities, developed Symptomatic disease (COVID-19), were intubated, and died. Patients with high viral load had longer stay in intensive care unit and longer intubation compared to patients with low viral load (P values < .05 for all comparisons). Patients with chronic cardiovascular disease, hypertension, chronic pulmonary disease, immunosuppression, obesity, and chronic neurological disease more often had high viral load (P value < .05 for all comparisons). In multivariate analysis high viral load was associated with COVID-19. Level of viral load was not associated with any other outcome.
CONCLUSIONS: URT viral load could be used to identify patients at higher risk for morbidity or severe outcome.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; clinical course; outcome; upper respiratory tract; viral load

Mesh:

Year:  2021        PMID: 33388780      PMCID: PMC7798974          DOI: 10.1093/infdis/jiaa804

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  31 in total

1.  SARS-CoV-2 viral-load distribution reveals that viral loads increase with age: a retrospective cross-sectional cohort study.

Authors:  Sjoerd Euser; Sem Aronson; Irene Manders; Steven van Lelyveld; Bjorn Herpers; Jan Sinnige; Jayant Kalpoe; Claudia van Gemeren; Dominic Snijders; Ruud Jansen; Sophie Schuurmans Stekhoven; Marlies van Houten; Ivar Lede; James Cohen Stuart; Fred Slijkerman Megelink; Erik Kapteijns; Jeroen den Boer; Elisabeth Sanders; Alex Wagemakers; Dennis Souverein
Journal:  Int J Epidemiol       Date:  2021-09-08       Impact factor: 7.196

2.  Immunomodulatory LncRNA on antisense strand of ICAM-1 augments SARS-CoV-2 infection-associated airway mucoinflammatory phenotype.

Authors:  Dinesh Devadoss; Arpan Acharya; Marko Manevski; Dominika Houserova; Michael D Cioffi; Kabita Pandey; Madhavan Nair; Prem Chapagain; Mehdi Mirsaeidi; Glen M Borchert; Siddappa N Byrareddy; Hitendra S Chand
Journal:  iScience       Date:  2022-06-30

3.  Initial Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load Is Associated With Disease Severity: A Retrospective Cohort Study.

Authors:  Dennis Souverein; Karlijn van Stralen; Steven van Lelyveld; Claudia van Gemeren; Milly Haverkort; Dominic Snijders; Robin Soetekouw; Erik Kapteijns; Evelien de Jong; Gonneke Hermanides; Sem Aronson; Bjorn Herpers; Jeroen den Boer; Alex Wagemakers; Sjoerd Euser
Journal:  Open Forum Infect Dis       Date:  2022-05-01       Impact factor: 4.423

Review 4.  Single-cell immunology of SARS-CoV-2 infection.

Authors:  Yuan Tian; Lindsay N Carpp; Helen E R Miller; Michael Zager; Evan W Newell; Raphael Gottardo
Journal:  Nat Biotechnol       Date:  2021-12-20       Impact factor: 68.164

Review 5.  Correlation of initial upper respiratory tract viral burden with progression to lower tract disease in adult allogeneic hematopoietic cell transplant recipients.

Authors:  Chikara Ogimi; Hu Xie; Alpana Waghmare; Keith R Jerome; Wendy M Leisenring; Filippo Milano; Janet A Englund; Michael Boeckh
Journal:  J Clin Virol       Date:  2022-04-04       Impact factor: 14.481

6.  SARS-CoV-2 is associated with high viral loads in asymptomatic and recently symptomatic healthcare workers.

Authors:  M Catherine McEllistrem; Cornelius J Clancy; Deanna J Buehrle; Nina Singh; Aaron Lucas; Valerie Sirianni; Brooke K Decker
Journal:  PLoS One       Date:  2021-03-18       Impact factor: 3.240

7.  High household transmission of SARS-CoV-2 in the United States: living density, viral load, and disproportionate impact on communities of color.

Authors:  Carla Cerami; Tyler Rapp; Feng-Chang Lin; Kathleen Tompkins; Christopher Basham; Meredith S Muller; Maureen Whittelsey; Haoming Zhang; Srijana B Chhetri; Judy Smith; Christy Litel; Kelly Lin; Mehal Churiwal; Salman Khan; Faith Claman; Rebecca Rubinstein; Katie Mollan; David Wohl; Lakshmanane Premkumar; Jonathan J Juliano; Jessica T Lin
Journal:  medRxiv       Date:  2021-03-12

Review 8.  Post-COVID Syndrome: An Insight on Its Pathogenesis.

Authors:  Helena C Maltezou; Androula Pavli; Athanasios Tsakris
Journal:  Vaccines (Basel)       Date:  2021-05-12

9.  SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome.

Authors:  Sonsoles Salto-Alejandre; Judith Berastegui-Cabrera; Pedro Camacho-Martínez; Carmen Infante-Domínguez; Marta Carretero-Ledesma; Juan Carlos Crespo-Rivas; Eduardo Márquez; José Manuel Lomas; Claudio Bueno; Rosario Amaya; José Antonio Lepe; José Miguel Cisneros; Jerónimo Pachón; Elisa Cordero; Javier Sánchez-Céspedes
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

10.  The SARS-CoV-2 viral load in COVID-19 patients is lower on face mask filters than on nasopharyngeal swabs.

Authors:  Agnieszka Smolinska; David S Jessop; Kirk L Pappan; Alexandra De Saedeleer; Amerjit Kang; Alexandra L Martin; Max Allsworth; Charlotte Tyson; Martine P Bos; Matt Clancy; Mike Morel; Tony Cooke; Tom Dymond; Claire Harris; Jacqui Galloway; Paul Bresser; Nynke Dijkstra; Viresh Jagesar; Paul H M Savelkoul; Erik V H Beuken; Wesley H V Nix; Renaud Louis; Muriel Delvaux; Doriane Calmes; Benoit Ernst; Simona Pollini; Anna Peired; Julien Guiot; Sara Tomassetti; Andries E Budding; Frank McCaughan; Stefan J Marciniak; Marc P van der Schee
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.